Further considerations towards an effective and efficient oncology drug discovery DMPK strategy.
CONCLUSION: Application of our updated drug-drug interaction and central nervous system drug exposure strategies are exemplified, as is the impact of physiologically based pharmacokinetic and pharmacokinetic-pharmacodynamic modelling, for human predictions.
PMID: 32164508 [PubMed - as supplied by publisher]
Source: Current Drug Metabolism - Category: Drugs & Pharmacology Authors: Williamson B, Colclough N, Fretland A, Jones B, Owen R, McGinnity D Tags: Curr Drug Metab Source Type: research
More News: AstraZeneca | Cancer & Oncology | Cardiology | Clinical Trials | Drugs & Pharmacology | Heart | Study